Literature DB >> 18369706

Bilateral neovascular glaucoma due to multicentric Castleman disease.

Takayasu Omata, Teruhiko Hamanaka, Soichiro Ikushima, Masaru Oritsu.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18369706     DOI： 10.1007/s10384-007-0486-6

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN： 0021-5155            Impact factor:   2.447


× No keyword cloud information.
  6 in total

1.  Anti-erythropoietin antibodies in hyperviscosity syndrome associated with giant lymph node hyperplasia (GLNH; Castleman's disease).

Authors:  J J Steinberg; P L Huang; P Ljubich; S Lee-Huang
Journal:  Br J Haematol       Date:  1990-04       Impact factor: 6.998

2.  Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease.

Authors:  Norihiro Nishimoto; Yuzuru Kanakura; Katsuyuki Aozasa; Takeshi Johkoh; Minoru Nakamura; Shuji Nakano; Nobuaki Nakano; Yasuo Ikeda; Takeshi Sasaki; Kiyoshi Nishioka; Masamichi Hara; Hirokuni Taguchi; Yukihiko Kimura; Yoshiro Kato; Hideki Asaoku; Shunichi Kumagai; Fumio Kodama; Hideko Nakahara; Keisuke Hagihara; Kazuyuki Yoshizaki; Tadamitsu Kishimoto
Journal:  Blood       Date:  2005-07-05       Impact factor: 22.113

3.  Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease.

Authors:  K Yoshizaki; T Matsuda; N Nishimoto; T Kuritani; L Taeho; K Aozasa; T Nakahata; H Kawai; H Tagoh; T Komori
Journal:  Blood       Date:  1989-09       Impact factor: 22.113

4.  Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations.

Authors:  A R Keller; L Hochholzer; B Castleman
Journal:  Cancer       Date:  1972-03       Impact factor: 6.860

5.  Iatrogenic central retinal vein occlusion and hyperviscosity associated with high-dose intravenous immunoglobulin administration.

Authors:  K T Oh; H C Boldt; R P Danis
Journal:  Am J Ophthalmol       Date:  1997-09       Impact factor: 5.258

6.  [A case of Castleman's disease with a variable neuropsychiatric symptomatology].

Authors:  H Nakayama; Y Nakano; N Itoh; R Koike; A Honma; M Takahashi; T Gotoh
Journal:  No To Shinkei       Date:  1992-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.